SLC19A2 and diabetes mellitus: Four genetic defects are reported: three with a predominantly neurological phenotype (SLC19A3, SLC25A19 and TPK1) and one with a multisystem disease (SLC19A2), including megaloblastic anaemia, thrombocytopenia, diabetes and hearing loss [17,18].